Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening

European Journal of Human Genetics

Volumn 24, Issue 2, 2016, Pages 171-177

  Holtkamp, Kim C A ^a   Van Maarle, Merel C ^b   Schouten, Maria J E ^a   Dondorp, Wybo J ^c   Lakeman, Phillis ^b   Henneman, Lidewij ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANCESTRY GROUP; ARTICLE; ATTITUDE; COMMUNITY; DISEASE CARRIER; FEMALE; HEALTH CARE COST; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; ONLINE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCREENING; STIGMA; ADOLESCENT; AGED; FOUNDER EFFECT; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HETEROZYGOTE; HETEROZYGOTE DETECTION; MIDDLE AGED; NETHERLANDS; PREGNANCY; PRENATAL DIAGNOSIS;

ADOLESCENT; ADULT; AGED; FEMALE; FOUNDER EFFECT; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; JEWS; MALE; MIDDLE AGED; NETHERLANDS; PREGNANCY; PRENATAL DIAGNOSIS; SURVEYS AND QUESTIONNAIRES;

EID: 84954374849     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2015.97     Document Type: Article

References (31)

1. Risch N, Tang H, Katzenstein H, Ekstein J: Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection. Am J Hum Genet 2003; 72: 812-822.
2. Ekstein J, Katzenstein H: The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease. Adv Genet 2001; 44: 297-310.
3. Frumkin A, Raz AE, Plesser-Duvdevani M, Lieberman S: 'The Most Important Test You'll Ever Take'?: Attitudes toward confidential carrier matching and open individual testing among modern-religious Jews in Israel. Soc Sci Med 2011; 73: 1741-1747.
4. Gason AA, Metcalfe SA, Delatycki MB et al: Tay Sachs disease carrier screening in schools: Educational alternatives and cheekbrush sampling. Genet Med 2005; 7: 626-632.
5. Ioannou L, Massie J, Lewis S et al: Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools. Clin Genet 2010; 78: 21-31.
6. Klugman S, Gross SJ: Ashkenazi Jewish screening in the twenty-first century. Obstet Gynecol Clin North Am 2010; 37: 37-46.
7. Kaback MM: Screening and prevention in Tay-Sachs disease: origins, update, and impact. Adv Genet 2001; 44: 253-265.
8. Ferreira JC, Schreiber-Agus N, Carter SM, Klugman S, Gregg AR, Gross SJ: Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze. Am J Obstet Gynecol 2014; 211: 197-204.
9. Hoffman JD, Park JJ, Schreiber-Agus N et al: The Ashkenazi Jewish carrier screening panel: evolution, status quo, and disparities. Prenat Diagn 2014; 34: 1161-1167.
10. ACOG: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol 2009; 114: 950-953. ACOG Committee Opinion No: 442.
11. Gross SJ, Pletcher BA, Monaghan KG: Carrier screening in individuals of Ashkenazi Jewish descent. Genet Med 2008; 10: 54-56.
12. Scott SA, Edelmann L, Liu L, Luo M, Desnick RJ, Kornreich R: Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases. Hum Mutat 2010; 31: 1240-1250.
13. Leib JR, Gollust SE, Hull SC, Wilfond BS: Carrier screening panels for Ashkenazi Jews: is more better? Genet Med 2005; 7: 185-190.
14. Grody WW: Expanded carrier screening and the law of unintended consequences: from cystic fibrosis to fragile X. Genet Med 2011; 13: 996-997.
15. Grody WW, Thompson BH, Gregg AR et al: ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med 2013; 15: 482-483.
16. Van Solinge H, Van Praag C: [The Jews in the Netherlands in 2009: Continuity and Change]. Diemen, The Netherlands: AMB, 2010.
17. Fossey E, Harvey C, McDermott F, Davidson L: Understanding and evaluating qualitative research. Aust N Z J Psychiatry 2002; 36: 717-732.
18. Warsch J, Warsch S, Herman E et al: Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience. J Community Genet 2014; 5: 223-231.
19. Hegwer G, Fairley C, Charrow J, Ormond KE: Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program. J Genet Counsel 2006; 15: 61-70.
20. Laberge AM, Watts C, Porter K, Burke W: Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia. Public Health Genomics 2010; 13: 310-319.
21. Barlow-Stewart K, Burnett L, Proos A et al: A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet 2003; 40: e45.
22. Raz AE, Vizner Y: Carrier matching and collective socialization in community genetics: Dor Yeshorim and the reinforcement of stigma. Soc Sci Med 2008; 67: 1361-1369.
23. Sheeran P: Intention-behavior relations: a conceptual and empirical review. Eur Rev Soc Psychol 2002; 12: 1-36.
24. Lazarin GA, Haque IS, Nazareth S et al: An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. Genet Med 2013; 15: 178-186.
25. Jans SMPJ, Henneman L, De Jonge A et al: 'A morass of considerations': exploring attitudes towards ethnicity-based haemoglobinopathy-carrier screening in primary care. Fam Pract 2013; 30: 604-610.
26. Stoll K, Resta R: Considering the cost of expanded carrier screening panels. Genet Med 2013; 15: 318-319.
27. De Wert G, Dondorp W, Knoppers B: Preconception care and genetic risk: ethical issues. J Community Genet 2012; 3: 221-228.
28. Zuckerman S, Lahad A, Shmueli A: Carrier screening for gaucher disease: Lessons for low-penetrance, treatable diseases. JAMA 2007; 298: 1281-1290.
29. Teeuw ME, Loukili G, Bartels EA, Ten Kate LP, Cornel MC, Henneman L: Consanguineous marriage and reproductive risk: attitudes and understanding of ethnic groups practising consanguinity in Western society. Eur J Hum Genet 2014; 22: 452-457.
30. Henneman L, Ten Kate LP: Preconceptional couple screening for cystic fibrosis carrier status: couples prefer full disclosure of test results. J Med Genet 2002; 39: e26.
31. Statistics Netherlands: Voorburg/Heerlen. 2014. Available at www.cbs.nl (accessed on 14 November 2014).